Literature DB >> 10699739

Lymph node metastases: CT and MRI.

M W van den Brekel1.   

Abstract

Imaging is playing a major role in the assessment of cervical lymphadenopathy. In head and neck malignancies, imaging can be helpful for staging, and sometimes in differentiating different types of metastases, such as squamous cell carcinomas, non-hodgkins disease and thyroid carcinomas. This article on imaging of cervical lymph node metastases will describe both radiological and clinical aspects. Computed tomography (CT) and magnetic resonance (MR) are widely used for primary tumor and nodal imaging. However, very seldom these modalities have clinical consequences for the management of the neck, such as a wait-and-see policy if no nodes are depicted. This is caused by the limited accuracy of both modalities caused by the fallibility of radiologic criteria for metastases. Ultrasound (US) is hampered by similar morphologic criteria, and only US-guided fine needle aspiration cytology (FNAC) can offer additional cytologic criteria which are more reliable.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10699739     DOI: 10.1016/s0720-048x(99)00145-x

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  25 in total

1.  Indium-111 octreotide scintigraphy for the detection of non-functioning metastases from differentiated thyroid cancer: diagnostic and prognostic value.

Authors:  Marcel P M Stokkel; Robbert B Verkooijen; Jan W A Smit
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-02-26       Impact factor: 9.236

Review 2.  Role of sentinel node biopsy in the management and staging of the N0 neck.

Authors:  Gary L Ross; Taimur Shoaib
Journal:  Odontology       Date:  2005-09       Impact factor: 2.634

3.  Efficiency of ultrasound-guided aspiration of medial retropharyngeal lymph node in dogs.

Authors:  Changseok Kim; Michelle L Oblak; Stephanie Nykamp
Journal:  Can Vet J       Date:  2019-06       Impact factor: 1.008

4.  MRI sequences for the detection of individual lymph nodes in regional breast radiotherapy planning.

Authors:  Tristan C F van Heijst; Bram van Asselen; Ruud M Pijnappel; Marissa Cloos-van Balen; Jan J W Lagendijk; Desirée van den Bongard; Mariëlle E P Philippens
Journal:  Br J Radiol       Date:  2016-05-10       Impact factor: 3.039

5.  Value of a Dixon-based MR/PET attenuation correction sequence for the localization and evaluation of PET-positive lesions.

Authors:  Matthias Eiber; Axel Martinez-Möller; Michael Souvatzoglou; Konstantin Holzapfel; Anja Pickhard; Dennys Löffelbein; Ivan Santi; Ernst J Rummeny; Sibylle Ziegler; Markus Schwaiger; Stephan G Nekolla; Ambros J Beer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-06-18       Impact factor: 9.236

Review 6.  Contrast-enhanced MR imaging of lymph nodes in cancer patients.

Authors:  Seung Hong Choi; Woo Kyung Moon
Journal:  Korean J Radiol       Date:  2010-06-21       Impact factor: 3.500

7.  Non-contrast-enhanced CT findings of high attenuation within metastatic cervical lymph nodes in patients with stage I or II tongue carcinoma during a follow-up period.

Authors:  Takafumi Hayashi; Ray Tanaka; Shuhzou Taira; Jun-ichi Koyama; Kouji Katsura; Fukiko Kobayashi
Journal:  AJNR Am J Neuroradiol       Date:  2003-08       Impact factor: 3.825

8.  Enhancement of anatomical structures and detection of metastatic cervical lymph nodes: comparison of two different contrast material doses.

Authors:  Haruo Watanabe; Masayuki Kanematsu; Hiroki Kato; Toshihisa Kojima; Toshiharu Miyoshi; Satoshi Goshima; Hiroshi Kondo; Hiroshi Kawada; Yoshifumi Noda; Noriyuki Moriyama
Journal:  Jpn J Radiol       Date:  2012-09-25       Impact factor: 2.374

9.  Discrimination of metastatic cervical lymph nodes with diffusion-weighted MR imaging in patients with head and neck cancer.

Authors:  Misa Sumi; Noriyuki Sakihama; Tadateru Sumi; Minoru Morikawa; Masataka Uetani; Hiroyuki Kabasawa; Koichiro Shigeno; Kuniaki Hayashi; Haruo Takahashi; Takashi Nakamura
Journal:  AJNR Am J Neuroradiol       Date:  2003-09       Impact factor: 3.825

10.  Indium-111-Octreotide scintigraphy in differentiated thyroid carcinoma metastases that do not respond to treatment with high-dose I-131.

Authors:  Marcel P M Stokkel; Henna I E Reigman; Robbert B T Verkooijen; Jan W Smit
Journal:  J Cancer Res Clin Oncol       Date:  2003-05-15       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.